CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
| Pennsylvania | 1-31070 | 23-2328753 |
| (State or other jurisdiction | (Commission | (IRS employer |
| of incorporation) | File Number) | identification number) |
Derma Sciences, Inc. (the “Registrant”) as of February 28, 2002 concluded subscription agreements with its President, Edward J. Quilty, together with 15 other individual and institutional investors for the sale of 1,300,000 shares of the Registrant’s common stock, par value $0.01 per share (“Common Stock”), at a price of $0.50 per share, for a total investment of $650,000. Subscriptions totaling $565,000 have been funded. The Registrant expects the balance of the subscriptions to be funded not later than March 31, 2002. The Registrant has agreed to file a registration statement with the Securities and Exchange Commission relative to the Common Stock.
The Purchase Agreement, Registration Rights Agreement and Legal Opinion relative to the Common Stock are attached hereto as Exhibits 10.01, 10.02 and 10.03, respectively.
| (a) | Not applicable |
| (b) | Not applicable |
| (c) | Exhibits: |
| 10.01 – Purchase Agreement | |
| 10.02 – Registration Rights Agreement | |
| 10.03 – Legal Opinion |
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| DERMA SCIENCES, INC. | ||
| Date: March 5, 2002 | By: /s/ John E. Yetter John E. Yetter, CPA Vice President and Chief Financial Officer |
3